How Health Care in America Became Big Business–And Bad Medicine – OpEd NYT – Zoloft NYT Ad Fails to Disclose Suicide risk

How Health Care in America Became Big Business–And Bad Medicine – OpEd NYT Zoloft NYT Ad Fails to Disclose Suicide risk Mon, 25 Oct 2004 An Op-Ed in Sunday’ New York Times by Time magazine editors, Donald Barlett and James Steele, is a MUST READ assessment of what ails America’s…

Glaxo chief executive angry over NYS AG lawsuit – Telegraph

Glaxo chief executive angry over NYS AG lawsuit – Telegraph Tue, 8 Jun 2004 The significance of the lawsuit filed by NYS Attorney General, Eliot Spitzer, has infuriated Jean-Pierre Garnier, GlaxoSmithKline’s CEO. As Money.Telegraph (UK) reports (below), the AG suit carries a significance beyond the money sought. “Reputationally, however, the…

Will the Cong Oversight / Investigations Committee Ask FDA the Tough Questions?

Will the Cong Oversight / Investigations Committee Ask FDA the Tough Questions? Wed, 22 Sep 2004 FDA’s complicity in concealing vital drug safety information that might have saved lives, is the subject of tomorrow’s hearing by the House subcommittee on Oversight and Investigations. Rayburn Office Bldg, room 2123 at 11:00….

Medicare Will cover New Treatments But Patients Will be Required to Enroll in Clinical Trials

Medicare Will cover New Treatments But Patients Will be Required to Enroll in Clinical Trials Fri, 5 Nov 2004 Dr. Mark McClellan, Director of Medicare, estimates that of Medicare’s $320 billion budget, “a third of all medical expenditures are for unnecessary or ill-advised treatments.” Medicare’s chief medical officer, Dr. Sean…

Calls Mounting for FDA Revamp / Americans Are the most medicated population in the world – DHHS

Calls Mounting for FDA Revamp / Americans Are the most medicated population in the world – DHHS Sun, 26 Dec 2004 A government survey by the U.S. Department of Health and Human Services, confirms that Americans are the most medicated population in the world – 44 percent of Americans had…

Worldwide Drug Industry Ailing – PhaRMA Giants Reeling Blockbuster Drugs Found Hazardous

Worldwide Drug Industry Ailing – PhaRMA Giants Reeling Blockbuster Drugs Found Hazardous Sat, 18 Dec 2004 Daily headlines provide confirmatory evidence supporting what critics of the drug industry have been say:ing for years. First, as The New York Times notes in one of its 4 articles about the latest “unexpected”…

Cong Committee Chair Requests antidepressant drug FACTS

Cong Committee Chair Requests antidepressant drug FACTS Thu, 5 Feb 2004 The Alliance for Human Research Protection applauds Congressman James Greenwood, Chaiman of the investigative panel of the House Committee on Energy & Commerce, who in two sentences got to the heart of the problem currently undermining the public’s health–most…

Expert FDA Report: SSRI Suicide risk – SF Chronicle / NYT/ NJ Ledger/ AP

Expert FDA Report: SSRI Suicide risk_SF Chronicle / NYT/ NJ Ledger/ AP Fri, 16 Apr 2004 FDA officials have provoked congressional hearings at which they will have to explain, not only why they concealed data linking antidepressants to increased violent and suicidal behavior, and why they covered up a report…

Concealed Drug Trial Results Mislead Doctors & Put Children’s Lives at Risk – NYT

Concealed Drug Trial Results Mislead Doctors & Put Children’s Lives at Risk – NYT Thu, 22 Jul 2004 The inordinate influence that drug companies wield on government healthcare regulatory policies–through campaign contributions to elected officials and lucrative job offers to public officials–has seriously compromised children’s safety in numerous ways. An…

Fast growing business: Unethical clinical trials in India – Asia Times

Fast growing business: Unethical clinical trials in India – Asia Times Tue, 27 Jul 2004 Asia Times reports: “India increasingly emerges as a preferred destination for outsourcing clinical trials – testing of new drugs on humans – the country may also be heading toward providing the greatest source of human…

Lilly Withdraws Duloxetine Application from FDA

Lilly Withdraws Duloxetine Application from FDA Fri, 28 Jan 2005 Eli Lilly and Boeringer Ingelheim have jointly announced that they have recinded their U.S. FDA Application for Duloxetine for Treatment of Stress Urinary Incontinence. http://newsroom.lilly.com/ReleaseDetail.cfm?ReleaseID=154081&print=yes Withdrawal of an application from FDA approval process is usually the result of the manufacturer’s…